Profiel
Jeff Macdonald is currently Executive Director-Investor Relations at Jazz Pharmaceuticals Plc and will hold the same title at Vaxcyte, Inc. starting in 2025.
Former roles include Senior Director-Corporate Communications at Acorda Therapeutics, Inc. and Senior Director-Investor Relations at G1 Therapeutics, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Washington & Lee University.
Actieve functies van Jeff Macdonald
| Bedrijven | Functie | Begin |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Investor Relations Contact | - |
| VAXCYTE, INC. | Investor Relations Contact | 01-06-2025 |
Eerdere bekende functies van Jeff Macdonald
| Bedrijven | Functie | Einde |
|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Contact | 04-01-2021 |
| ACORDA THERAPEUTICS, INC. | Investor Relations Contact | 10-05-2012 |
Opleiding van Jeff Macdonald
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
















